Evogliptin tartrate
Product Specifications
CAS Number
1222102-51-3
Target
Proteasome, Autophagy, DPP-4
Related Pathways
Proteases/Proteasome, Autophagy, Ubiquitination
Bioactivity
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.
Smiles
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F
Molecular Formula
C23H32F3N3O9
Molecular Weight
551.51
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
207578 100 µg
DUX4 (DUX10, Double Homeobox Protein 4, Double Homeobox Protein 10) (ATTO 594)
Sign In for Pricing
View Details 
038089-HRP 200 µL
MAP1ALC3 (APG8A/B) (LC3, MAP1LC3B, MAP1ALC3, Microtubule-associated proteins 1A/1B light chain 3B, Autophagy-related protein LC3 B, Autophagy-related ubiquitin-like modifier LC3 B, MAP1 light chain 3-like protein 2, MAP1A/MAP1B light chain 3 B, Microtubule-associated protein 1 light chain 3 beta) (HRP) discontinued
Sign In for Pricing
View Details G7404 96 Tests
Retinoic Acid Receptor responder protein 1 (RARRES1) Human ELISA Kit
Sign In for Pricing
View Details 
